Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the company’s ELITE-BTK pivotal trial of Magnitude, its ...

November 11, 2024—iVascular announced the initiation of OPAL, a first-in-human study of Amber, the company’s embolic liquid ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

LeMaitre Vascular, Inc. Glow 'N Tell 55-cm Tape 55 Centimeter markings on flexible radiopaque ruler LeMaitre Vascular, Inc. Glow 'N Tell Tape 30 Centimeter markings on flexible radiopaque ruler ...

For as many as 200 million people around the world affected by peripheral artery disease (PAD), 1 the evolution of endovascular innovations certainly provides a source of optimism. Within 3 decades, ...

Akura Medical, a Shifamed portfolio company focused on venous thromboembolism care, announced recently that the FDA has approve ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Merit Medical Systems, Inc. Merit Advance Angiographic Needles 18, 19, 20, 21 (smooth and echo-enhanced) 2.5, 4, 7, 9 Merit Medical Systems, Inc. Merit Advance ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...